Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

How to Make Electronic Submission a Business Benefit

This article was originally published in SRA

Executive Summary

Many companies think of the electronic common technical document for submissions as a mere electronification of the CTD. They believe that implementing the eCTD essentially removes the printing processes while adding new processes for PDF rendition, bookmarking, hyperlinking and generation of the XML backbone. While this conception is not mistaken, it ignores important business potentials that the eCTD can offer a pharmaceutical company. Substantial business benefits such as reductions in submission times and costs could be achieved by companies if they approached the implementation of the eCTD as an opportunity to rethink their entire process hierarchy.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS114531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel